Disseminated infections with the fungal species Cryptococcus neoformans or, less 44 frequently, C. gattii, are a leading cause of mortality in immunocompromised 45 individuals. Central to the virulence of both species is an elaborate polysaccharide 46 capsule that consists predominantly of glucuronoxylomannan (GXM). Due to its 47 abundance, GXM is an ideal target for host antibodies, and several monoclonal 48 antibodies (mAbs) have previously been derived using purified GXM or whole 49 capsular preparations as antigen. In addition to their application in the diagnosis of 50 cryptococcosis, anti-GXM mAbs are invaluable tools for studying capsule structure. 51
virulence factor for both species is a highly variable polysaccharide capsule, 69 formation of Titan cells also underlies the pathogenesis of C. neoformans. Previous 70 studies have shown that capsule composition differs between yeast and Titan cells, 71 however no clear distinctions in the expression or localisation of specific capsular 72 epitopes have been made. In this study, we characterise a novel monoclonal 73 antibody (mAb) specific to a capsular epitope that is differentially distributed 74 throughout the capsules produced by yeast and Titan cells. Whilst this epitope is 75 found within the midzone of yeast capsules, the presentation of this epitope on the 76
Introduction 80

As the two main etiological agents of cryptococcosis, Cryptococcus neoformans and 81
Cryptococcus gattii are major contributors to the global health burden imposed by 82 invasive fungal infections (1). Whilst C. neoformans typically manifests as meningitis 83 in immunocompromised individuals, C. gattii infections are not associated with 84 specific immune defects and have been responsible for fatal outbreaks of pneumonia 85 (2-4). Central to the virulence of both species is an elaborate polysaccharide 86
Titan cells are structurally distinct from those produced by typical yeast cells (7, 11, 119 26). As the increased chitin content of cell walls produced by Titan cells is 120 associated with activation of a detrimental T H 2 immune response during 121 cryptococcosis (27), it is possible that hitherto unidentified structural differences in 122
Titan cell capsules also contribute to the modulation of host immunity by this C. 123 neoformans morphotype. antibodies are the most abundant isotype of antibody produced in response to GXM 129
(28). As a repetitive capsular polysaccharide, GXM is a T-independent type 2 130
antigen and antibodies generated against it utilise a restricted set of variable region 131 complexities of cryptococcal capsule structure with the ultimate aim of understanding 143 the strategies deployed by this fatal fungal pathogen to evade host immunity. 144
145
In the present study, we report the generation of Crp127, a murine IgM mAb, using a 146 cocktail of heat-killed C. neoformans H99 (serotype A), heat-killed C. gattii R265 147 (serotype B) and their lysates as an immunogen. Characterisation of Crp127 148 demonstrated that it is an O-acetyl-dependent anti-GXM mAb specific to an epitope 149 expressed by the four Cryptococcus serotypes in a serotype-specific manner. Having 150 subsequently found that this epitope is heterogeneously expressed within serotype B 151 populations and is spatially confined to distinct regions of the enlarged capsule 152 across all strains tested, we then turned our attention to its expression by Titan cells. 153
Intriguingly, we noticed that the spatial distribution of this epitope differs within the 154 capsules produced by the three C. neoformans morphotypes found within Titanising 155
populations. Further analysis revealed that, under conditions permissive for 156
Titanisation, cell enlargement coincides with the gradual redistribution of this epitopecorresponding wild-type strains, the GXM-deficient mutants were not recognised by 168
Crp127 (fig. 1A-C; cap10 P < 0.05; cap67 P < 0.01; cap59 P < 0.01; 169 cap59uge1 P < 0.01, Student's t-test). In contrast, the GXMGal-deficient uge1 170 mutant was bound at levels similar to the wild-type strain ( fig. 1C ; P > 0.05). 171
Confocal microscopy corroborated these observations, with no observable binding of 172
Crp127 to GXM-deficient mutants but clear binding of Crp127 to the GXMGal-173 deficient mutant ( fig. 1D-F 5C ). We also tested strain CA1508 (VGIIIb), a C. gattii strain that, to our 376 knowledge, has not previously been serotyped. Both flow cytometry and indirectH), implying that it is a serotype C strain. In combination with the data presented in 379 figure 3, our finding that four out of five serotype B strains were bound similarly by 380 fig. 6E-H ; left 426 panels). Notably, however, Crp127 reaction patterns differed from those elicited by 427 18B7, which also exhibited a highly refractive outer rim but lacked texture throughout 428 the capsule ( fig. 6E-H 
repeats. Tukey's multiple comparisons test was used to test for statistically 498
significant differences between the three groups (n=3) (** P < 0.01; *** P < 0.001). 499 500
Migration of the Crp127 epitope towards the surface of the capsule coincides 501 with cell enlargement 502
To investigate the effect of small changes in cell size on Crp127 epitope distribution, 503
we plotted cell body diameter against epitope proximity to the capsule surface for all 504 cells measured ( fig. 8A-B) . Having done so, we noticed a correlation between the 505 cell body diameter and epitope proximity to the capsule surface of yeast-like cells. In 506 agreement with this, when plotting only cells with a cell body diameter between 5-10 507 m, we found a positive correlation between cell body diameter and epitope 508 proximity to the capsule surface in both strains tested ( fig. 7F-G ; H99 r = 0.65; 509 Kn99 r = 0.66). Unlike cell body diameter, capsule diameter did not correlate with 510 epitope proximity to the capsule surface, indicating that changes in capsule size do 511 not explain changes in the proximity of the Crp127 to the capsule surface ( fig. S4) . 512 In this study, we demonstrated that a capsular epitope recognised by Crp127 -an 543 anti-GXM mAb produced in our laboratory -contributes to serotype-specific 544 Crp127 with four previously characterised anti-GXM IgM mAbs -namely 2D10, 556 12A1, 13F1 and 21D2 -we found that Crp127 CDRs were significantly different, 557 particularly with regard to the light-chain variable (V L ) CDRs. These differences 558 reflect differential gene usage and are likely to manifest as differences in epitope 559 specificity (41, 42). In contrast, when we aligned the heavy-chain variable (V H ) and 560 V L sequences from Crp127 with those from anti-GXM IgG1 mAb 302, we noticed that 561 the sequences were extremely similar as a result of identical variable region gene 562 segment usage by these two mAbs. Identical gene segment usage is not entirely 563 surprising given the restricted set of antibody gene segments utilised by antibodies 564 specific to capsular polysaccharides (29), however the two mAbs were produced in 565 response to GXM derived from different serotypes of Cryptococcus. Whereas mAb(ATCC 24064) (43), we generated Crp127 through the immunisation of a mouse with 568 a cocktail containing both serotype A (H99) and serotype B (R265) GXM. Whichever 569 serotype of GXM activated the B cell from which Crp127 derives, the sequence 570 similarities between mAbs Crp127 and 302 demonstrate that nearly identical 571 antibodies can be elicited during infection by at least two different serotypes of 572
Cryptococcus. 573 574
Crp127 binding shows strong serotype dependence, with serotype D strains being 575 recognised most strongly, followed by serotype A strains. C. gattii serotype B strains 576
show lower, heterogeneous Crp127 epitope recognition and a punctate 577 immunofluorescence binding pattern, whilst serotype C strains entirely fail to bind the 578 antibody. Interestingly, the predominant SRG found in GXM produced by serotype D, 579
A, B and C contains 1, 2, 3 and 4 xylose substituents, respectively (15, 44). Together 580 with the previous observation that -(1,2)-xylose and O-acetyl groups are not added 581 to the same backbone mannose residue (17, 36), this differential SRG usage may 582 explain the variable Crp127 epitope recognition in one of two ways. For example, the 583 additional xylose substituents present in the predominant SRG found in serotype B 584 and C GXM may prevent addition of O-acetyl groups in such a way that the Crp127 585 epitope is not formed. Alternatively, the extra xylose substituents found in these 586
SRGs may sterically hinder binding of Crp127 to its epitope. Studies that further 587 elucidate the roles of specific proteins in GXM biosynthesis -together with advances 588 in techniques that enable chemical synthesis of GXM oligosaccharides -will 589 enhance our understanding of molecular how epitope recognition is achieved by anti-590 GXM mAbs like Crp127. Intriguingly, a recent transcriptomics study identified CAS31 591 as being absent from the genome of strain CBS 10101, a serotype C isolate that wesubsequently found was not recognised by Crp127. Whilst we cannot rule out the 593 possibility that other factors contribute to the inability of Crp127 to recognise 594 serotype C strains, it is tempting to speculate that the loss of CAS31 function in this 595 lineage may explain its lack of reactivity with Crp127 (32, 34) . One possibility is that the epitope could be formed at the cell surface and then move 608 outwards as the capsular material elongates. Therefore, we speculate that since the 609 epitope moves outwards at a faster rate than the capsule expands, and since the 610 
Materials and methods 623
Reagents, strains and mAbs 624
All reagents were purchased from Sigma-Aldrich unless stated otherwise. The 625
Cryptococcus strains used in this study are described in table S1. The anti-GXM 626 mAbs used in this study are described in table S2. 627
628
Growth of cryptococci 629
Cryptococcus strains were preserved at -80C in MicroBank TM tubes (Thermo Fisher 630 Sequencing was performed by whole transcriptome shotgun sequencing (RNA-Seq). 665
In brief, hybridomas were cultured in Iscove's Modified Dulbecco's Media (IMDM) 666 supplemented with 10% FBS in an incubator at 37C and with 5% CO 2 . Total RNAwas extracted from cells and a barcoded cDNA library generated through RT-PCR 668 using a random hexamer. Sequencing was performed using an Illumina HiSeq 669 sequencer. Contigs were assembled and annotated for viable antibody sequences 670 (i.e those not containing stop codons) to confirm the species and isotype of mAb 671
Crp127 as murine and IgM, respectively. 672
673
Variable region gene usage was determined using VBASE2 software (46) and CDRs 674 were predicted using the Kabat numbering system (47). Heavy-chain variable (V H ) 675 and light-chain variable (V L ) sequences of mAb Crp127 were aligned with antibody 676 sequences that have previously been described (35, 48). Amino acid sequences 677 were aligned using Clustal Omega software (49) and annotated using ESpript 678 software (50). 679
680
Immunolabelling 681
Cryptococcus cells were immunostained for flow cytometry and microscopy 682 experiments. 1 mL of fungal culture was transferred to a 1.5 mL microcentrifuge 683 tube, microfuged (15,000 x g for 1 min) and washed 3x in PBS. Cell density was 684 determined using a haemocytometer and adjusted to 10 7 cells/mL in a final volume 685 of 200 L. 20 g/mL Crp127, F12D2, 18B7 or mouse anti-human IgG (IgM isotype 686 control) were added and samples mixed on a rotary wheel at 20 rpm for 1 h at room 687 temperature. Untreated cells for use in flow cytometry were left untreated. After 688 primary antibody treatment, samples were microfuged (15,000 x g for 1 min) and 689 washed 3x in PBS to remove unbound primary antibody. 2 g/mL Alexa-488-690 conjugated goat anti-mouse IgM (heavy chain) (Thermo Fisher Scientific), AlexaF(ab')2-Goat anti-Mouse IgG (H+L) (Thermo Fisher Scientific) were added to 693 antibody-treated samples and samples mixed on a rotary wheel at 20 rpm for 1 h at 694 room temperature. Secondary antibody was also added to isotype control samples 695 for flow cytometry. For microscopy experiments, 5 g/mL calcofluor-white (CFW) 696 was also added at this stage to label chitin. Following incubation with secondary 697 antibody, samples were again microfuged (15,000 x g for 1 min) and washed 3x to 698 remove unbound secondary antibody and CFW. collected from each well at a rate of 100 L/min until 10,000 events were recorded. 708
The 488 nm laser was used to detect primary antibody bound by Alexa-488-709 conjugated secondary antibodies, with the same voltage used to power the laser 710 within each experiment. Flow cytometry data was then analysed using FlowJo (v10) 711 software. Debris was excluded by using the FSC-A vs. SSC-A gating strategy, 712 followed by exclusion of doublets using the FSC-A vs. FSC-H gating strategy ( fig.  713   S5) . Where GXM-deficient mutants were analysed, samples were only gated to 714 exclude debris due to the inseparable large aggregates formed by these mutants as 715 a result of budding defects. After gating, histograms of fluorescence intensity werevalues were calculated by subtracting the MFI value of the mAb-treated sample by 718 the corresponding isotype control sample in the case of Crp127 or untreated sample 719 where 18B7 was used. Across all experiments, MFI values returned from isotype 720 control cells were extremely similar to those returned from untreated cells. 721
722
Confocal microscopy 723
Following the final washes of the immunostaining procedure, 2 L of stained 724 cryptococcal cells were spotted onto a glass slide and placed under a square glass 725 coverslip. Where visualisation of the capsule was necessary, 2 L Indian ink was 726 also added to the glass slide. Imaging was performed on a Nikon A1R laser 727 scanning confocal microscope using a 100x object lens and oil immersion. Alongside 728 transmitted light, 639 nm and 405 nm lasers were used to detect Alexa-647-729 conjugated secondary antibodies and CFW, respectively. For cells with small 730 capsules, Z-stacks spanning 8 m were generated using steps of 0.27 m. For 731 capsule-induced cells, Z-stacks were taken across 20 m using steps of 0.66 m. 732
Generation of maximum intensity projections (MIPs) and other image processing 733 was performed using NIS-Elements and ImageJ software. 734
735
Chemical de-O-acetylation of capsular GXM
Phagocytosis assays 743
Phagocytosis assays were performed using the murine macrophage-like J774A.1 744 cell line (mouse BALB/cN; ATCC ® TIB-67™). Cells were cultured in DMEM 745 supplemented with 2 mM L-glutamine, 100 U/mL penicillin, 100 U/mL streptomycin 746 and 10% FBS, before 1 x 10 5 cells were seeded onto round glass coverslips that had 747 been placed into wells of a flat-bottom 24-well plate and incubated for 24 h at 37C 748 and 5% CO 2 . Cells of strain R265 and Kn99 were opsonised with 18B7 or Crp127 749 as described for the first incubation of the immunostaining procedure. In the same 750 way, cells were opsonised with 10% AB-human serum alone or in combination with 751
Crp127. To achieve a multiplicity of infection (MOI) of 10, 10 6 R265 or Kn99 cells 752
were then resuspended in serum-free DMEM and added to each well of J774A. were then transferred into 3 mL HI-FCS in a plastic six-well plate and cultured for a 781 further 72 h at 37C and 5% CO 2 . Titanising populations were prepared for imaging 782 according to the method described for immunostaining. Imaging was performed on a 783
Nikon TE2000-U microscope using a 60x objective lens with oil immersion. 784
785
To quantify the proximity of the Crp127 epitope to the capsule surface was 786 quantified, ImageJ software was used to draw regions of interest (ROIs) around the 787 cell body, the immunofluorescence binding pattern of the Crp127 and the capsule 788 surface (as determined by Indian ink staining). For each cell measured, the area of 789 these three ROIs was determined before the area of the cell body was subtracted 790 from the areas calculated for both the Crp127 epitope ROI and the capsule surface 791 ROI as a means of quantifying the proximity of the Crp127 epitope to the capsule 793 surface. A mean number of 111 and 133 cells were measured per biological replicate 794 for strain H99 and Kn99, respectively. Image processing was performed using NIS-795 Elements software. 796
797
Experimental design and statistical analysis 798
For each experiment described, three biological repeats were performed as 799 independent experiments that were carried out on different days. All datasets were 800 analysed using GraphPad Prism 7 software. 801 802
